IMS Health Reports Celebrex U.S. Prescriptions Dispensed Reach 299,571 in Third Week of March
(Last updated 4:27 PM ET March 26)
LONDON (BW HealthWire) -
IMS HEALTH (NYSE:RX) today
reported that for the week ending
March 19, total Celebrex prescriptions dispensed in the U.S.
reached 299,571, up 7.3 percent from the previous week. The
rate of mail order prescriptions rose as well, up 5.4 percent from
the second week of March, to 16,128 prescriptions. IMS
HEALTH's regular weekly prescription activity report covering
the week ending March 19 becomes available on Monday, March
29. IMS HEALTH is the world's leading provider of information
solutions to the pharmaceutical and healthcare industries.
In the ten weeks since its introduction in the U.S., a total of 1.5
million Celebrex prescriptions have been dispensed. The majority
of weekly Celebrex prescriptions continues to be new
prescriptions, which represented 82 percent of prescribing for the
week ending March 19. The remaining 18 percent, or 53,620
Celebrex prescriptions, were refills.
IMS HEALTH's weekly prescription tracking service provides
comprehensive coverage of three U.S. retail channels -- chain
drugstores, independent pharmacies and food stores with
pharmacies -- and includes cash and Medicaid prescriptions as
well as third-party reimbursement. The service also provides
unique access to mail-order prescriptions, making it the most
complete market tracking service covering the U.S.
pharmaceutical industry.
IMS HEALTH is the world's leading provider of information
solutions to the pharmaceutical and healthcare industries. With
more than $1.2 billion in 1998 revenue, IMS HEALTH operates
in over 90 countries. IMS HEALTH is the largest pharmaceutical
manufacturer information partner, with over 40 years' experience
in the industry. Key products and services integral to customer
day-to-day operations include: market research for prescription
and over-the-counter pharmaceutical products; sales management
information to optimize sales force productivity;
technology-enabled selling solutions for sales and marketing
decision making; and technology systems and information services
that support managed care organizations. Additional information
and previous press releases are available at the IMS HEALTH
website: imshealth.com.
nt.excite.com |
